drug
Qvar Redihaler
Marketedupdated 3mo agoby Teva Respiratory LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 17 investigational indications.
indications
investigational
Asthma
all catalysts(0)
nothing on the calendar yet
Trials studying Qvar Redihaler
- phase3A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
- phase3Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)
- phase3Functional Respiratory Imaging Study (DARWiIN)
- phase3Study in Adult Patients With Moderate to Severe Asthma
- phase3A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD
- phase1Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®
- phase4Linear Growth Study (0476-097)(COMPLETED)
- phase2To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 17, 2031
~4.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Aug 19, 2041formulationUS 11583643
- Aug 19, 2041formulationUS 11583643
- May 5, 2041formulationUS 11957832
- May 5, 2041formulationUS 11957832
- Jul 21, 2039formulationUS 11559637
- Jul 21, 2039formulationUS 11559637
- Jan 25, 2039formulationUS 10792447
- Jan 25, 2039formulationUS 10792447
- Jan 26, 2038formulationUS 11395888
- Jan 26, 2038formulationUS 11395888
- Jan 26, 2038formulationUS 11793953
- Jan 26, 2038formulationUS 11793953
- Jan 26, 2038formulationUS 12296089
- Jan 26, 2038formulationUS 12296089
- Oct 21, 2031formulationUS 10188811
- Oct 21, 2031formulationUS 10188811
- Jul 17, 2031formulationUS 89314764.9y
- Jul 17, 2031formulationUS 89314764.9y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 53m ago
Found something off?
comments(0)
5-min edit window · permanent after that